Free Trial

aTyr Pharma (ATYR) Insider Trading & Ownership

aTyr Pharma logo
$0.92 -0.12 (-11.37%)
Closing price 04:00 PM Eastern
Extended Trading
$0.92 0.00 (-0.09%)
As of 07:07 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

aTyr Pharma (NASDAQ:ATYR) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
5.75%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$912.72K
Number Of
Insiders Selling
(Last 12 Months)
3
Amount Of
Insider Selling
(Last 12 Months)
$6.29K
Get ATYR Insider Trade Alerts

Want to know when executives and insiders are buying or selling aTyr Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ATYR Insider Buying and Selling by Quarter

aTyr Pharma Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/4/2026Sell1,558$0.98$1,526.84  
2/4/2026
Nancy Denyes
Nancy Denyes
General Counsel
Sell1,118$0.98$1,095.64  
2/4/2026
Sanjay Shukla
CEO
Sell3,745$0.98$3,670.10  
10/9/2025Buy317,999$0.94$298,919.06  
10/8/2025Buy682,001$0.90$613,800.90  
(Data available from 1/1/2013 forward)

ATYR Insider Trading Activity - Frequently Asked Questions

The list of insiders at aTyr Pharma includes Jane A Gross, Jill Marie Broadfoot, Nancy Denyes, Paul Schimmel, and Sanjay Shukla. Learn more on insiders at ATYR.

5.75% of aTyr Pharma stock is owned by insiders. Learn more on ATYR's insider holdings.

The following insiders have purchased ATYR shares in the last 24 months: Jane A Gross ($15,000.00), and Paul Schimmel ($1,085,089.44).

Insiders have purchased a total of 1,097,102 ATYR shares in the last 24 months for a total of $1,100,089.44 bought.

The following insiders have sold ATYR shares in the last 24 months: Jill Marie Broadfoot ($6,266.96), Nancy Denyes ($4,493.86), and Sanjay Shukla ($3,670.10).

Insiders have sold a total of 8,574 aTyr Pharma shares in the last 24 months for a total of $14,430.92 sold.



This page (NASDAQ:ATYR) was last updated on 5/7/2026 by MarketBeat.com Staff.
From Our Partners